In conventional cardiovascular risk assessment, sleep barely registers. Patients get assessed for blood pressure, cholesterol, family history, sometimes diabetes. Sleep gets mentioned, if at all, as a lifestyle factor.
The data does not support that level of de-emphasis. Chronic short sleep is now well-established as an independent cardiovascular risk factor with effect sizes comparable to obesity and smoking. For a patient working on their cardiovascular trajectory, addressing sleep is one of the higher-leverage interventions available, and almost no one does it well.
What the data shows
Several large studies have established the relationship clearly.
The American Heart Association added sleep duration to its essential cardiovascular health metrics in 2022. The shift was based on consistent evidence that sleep duration predicts cardiovascular events independently of every other risk factor measured.
Chronic sleep under six hours doubles cardiovascular event risk in most studies, even after adjusting for obesity, diabetes, hypertension, and other confounders.
Sleep apnea, untreated, multiplies risk further. The intermittent oxygen drops drive vascular damage, blood pressure variability, and inflammation. Patients with untreated severe sleep apnea have cardiovascular event rates several times higher than matched controls.
Both too little and too much correlate with risk. The relationship is U-shaped, with optimal sleep around 7 to 8 hours. Patients sleeping over nine hours regularly have elevated risk, though this is usually because long sleep durations are markers of other underlying problems (depression, sleep disorders, chronic illness) rather than a direct cause.
The mechanisms
Several specific pathways link sleep loss to cardiovascular damage.
Blood pressure dysregulation. Sleep is when blood pressure should drop (the nocturnal dip). In chronic short sleepers, this dip is blunted. Average 24-hour blood pressure runs higher, driving long-term vascular damage.
Inflammation. Chronic short sleep elevates hsCRP, IL-6, and other inflammatory markers. Inflammation is one of the central drivers of atherosclerosis.
Sympathetic nervous system activation. Short sleep keeps the fight or flight system more active. Heart rate variability drops. The autonomic balance shifts in a cardioprotective-unfavorable direction.
Insulin resistance and metabolic syndrome. Both develop with chronic sleep loss and both drive cardiovascular risk.
Endothelial dysfunction. The lining of blood vessels does its repair work overnight. Chronic sleep loss measurably impairs endothelial function within weeks.
Cortisol pattern disruption. A flat cortisol curve drives visceral fat accumulation and metabolic disease.
What I monitor in patients with cardiovascular risk
For any patient I see with cardiovascular concerns, I assess:
- Total sleep duration, both average and consistency
- Sleep timing consistency (social jet lag)
- Sleep apnea risk markers, including snoring, neck circumference, witnessed apneas, daytime fatigue
- Resting heart rate and HRV trends from wearables when available
- Nocturnal blood pressure in selected patients with hypertension or specific concerns
If sleep is not in order, addressing it is part of the cardiovascular intervention. Not as an adjunct. As a primary lever.
The interventions for cardiovascular protection
The high-value moves:
Get seven to nine hours, consistently. A floor for any patient working on cardiovascular trajectory.
Test for sleep apnea aggressively. The signs are easy to overlook. If a patient snores, has unexplained morning headaches, daytime fatigue despite adequate sleep duration, witnessed apneas, or treatment-resistant hypertension, get a sleep study. Treatment of sleep apnea reduces cardiovascular event risk substantially.
Address obesity if it is in the picture. Sleep apnea, insulin resistance, and cardiovascular disease are all worsened by obesity. The interventions stack.
Reduce evening alcohol. Wrecks sleep architecture and raises blood pressure variability.
Treat insomnia structurally. Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment and works better than medication for long-term outcomes.
What this is not
I am not telling patients to ignore the conventional cardiovascular risk factors. ApoB, blood pressure, exercise, diet, smoking cessation, family history. All of those are real and I treat them aggressively when the data supports it.
Sleep belongs on the same list. If you have a cardiovascular case and have not had sleep addressed seriously, the path in is the Precision Call. I will tell you what I see.
